Standard BioTools Inc.LABNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank71
3Y CAGR+59.7%
5Y CAGR+7.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+59.7%/yr
vs -25.3%/yr prior
5Y CAGR
+7.2%/yr
Recent acceleration
Acceleration
+85.0pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.70 | +69.6% |
| 2024 | 2.77 | +33.1% |
| 2023 | 2.08 | +80.6% |
| 2022 | 1.15 | -60.4% |
| 2021 | 2.91 | -12.4% |
| 2020 | 3.32 | +43.9% |
| 2019 | 2.31 | -37.7% |
| 2018 | 3.70 | +13.9% |
| 2017 | 3.25 | -8.5% |
| 2016 | 3.55 | - |